Cellares is gearing up to unveil a major investment it is making here in the great Garden State. As NJBIZ reported in August, the San Francisco-headquartered cell therapy manufacturer secured $255 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback